The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study.
Tomislav BožekInes Bilić ĆurčićMaja Cigrovski BerkovićMarina GradišerTina Tićinović KurirSanja Klobučar MajanovićSrećko MarušićPublished in: Diabetology & metabolic syndrome (2018)
These results indicate that lixisenatide add on basal insulin treatment (BIT) can improve glycemic control in a population with long-standing type 2 diabetes and previously uncontrolled on other insulin therapy.
Keyphrases
- type diabetes
- glycemic control
- blood glucose
- end stage renal disease
- newly diagnosed
- insulin resistance
- cardiovascular disease
- weight loss
- ejection fraction
- systematic review
- randomized controlled trial
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- combination therapy
- bone marrow
- metabolic syndrome
- mesenchymal stem cells